Randomization design
Configure protocol-defined allocation, treatment arms, cohorts and controlled randomization rules for the study design.
Randomization and trial supply
Galax IWRS brings participant randomization and investigational-product supply into the same system. It reduces manual reconciliation and shipment risk while giving authorized study teams a clear view from enrollment through accountability.
Turn fragmented trial operations into one connected, transparent process.
Capabilities
Product capabilities are organized around the work study teams need to control, review and deliver—not around disconnected technical features.
Configure protocol-defined allocation, treatment arms, cohorts and controlled randomization rules for the study design.
Give authorized site users a guided enrollment and assignment workflow with immediate confirmation and role-based visibility.
Track investigational-product availability across depots and sites, supporting study-level inventory oversight.
Connect enrollment demand with resupply decisions to reduce avoidable shortages, excess stock and manual handoffs.
Maintain a controlled history of assignments, dispensing and inventory movements to support closeout reconciliation.
Use role-based access, operational dashboards and audit records to keep sponsor, CRO and site activities visible.
Delivery workflow
Connect IWRS with Galax EDC for participant and visit context and with eTMF for controlled study documentation and inspection readiness.
Translate allocation, cohort and supply rules from the protocol.
Enroll and assign participants through a controlled site workflow.
Monitor inventory and coordinate site or depot resupply.
Review assignments and inventory movements through closeout.
Quality and control
Platform controls and documented operating procedures work together to support the sponsor's validated, risk-based use.
Permissions limit randomization, supply and oversight activities to authorized study roles.
Protocol rules and production changes follow defined review and release controls.
Key participant, treatment and supply actions remain attributable and time-stamped.
Operational records and reports support sponsor oversight and trial reconciliation.
The connected suite
Contact
Share your protocol synopsis, current workflow or delivery gap. We will respond with an achievable configuration and validation approach.
info@galaxbiotech.com